The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Role of Nucleosomal Occupancy in the Epigenetic Silencing of the MLH1 CpG Island
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jones, P. A., & Baylin, S. B. (2007) · Cell · doi:10.1016/j.cell.2007.01.029 · Cited by 4,515
Self-citationHeintzman, N. D., Stuart, R. K., Hon, G., Fu, Y., Ching, C. W., Hawkins, R. D., Barrera, L. O., Van Calcar, S., Qu, C., Ching, K. A., et al. (2007) · Nature Genetics · doi:10.1038/ng1966 · Cited by 3,398 · cited 3×
“The objective of this study was to explore additional determinants such as the role of nucleosomal occupancy in CpG island silencing in cancer because this has been implicated in transcriptional control in yeast, flies, and humans (Bernstein et al., 2004; Heintzman et al., 2007; Lee et al., 2004; Lieb and Clarke, 2005…”
BackgroundFrommer, M., McDonald, L. E., Millar, D. S., Collis, C. M., Watt, F., Grigg, G. W., Molloy, P. L., & Paul, C. L. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.5.1827 · Cited by 3,238 · cited 2×
“Genomic DNA was treated with sodium bisulfite as previously described (Frommer et al., 1992).”
MethodEpigenetics in human disease and prospects for epigenetic therapy
Egger, G., Liang, G., Aparicio, A., & Jones, P. A. (2004) · Nature · doi:10.1038/nature02625 · Cited by 3,232
Self-citationGenomic DNA methylation: the mark and its mediators.
Klose, R. J., & Bird, A. P. (2006) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2005.12.008 · Cited by 2,501 · cited 1×
“Methyl-binding proteins such as MBD1, MBD2, or MeCP2 are likely to be involved in silencing of methylated promoters (Klose and Bird, 2006), and we have documented the presence of MeCP2 at methylated CpG islands associated with tumor suppressor genes (Nguyen et al., 2001, 2002).”
BackgroundCellular differentiation, cytidine analogs and DNA methylation
Jones, P. A., & Taylor, S. M. (1980) · Cell · doi:10.1016/0092-8674(80)90237-8 · Cited by 1,831 · cited 1×
“Treatment of both cell lines (SW48 and RKO) with the demethylating agent 5-aza-CdR for 24 hr (Jones and Taylor, 1980) caused a decrease in the level of CpG methylation, with a concordant reactivation of all three transcripts (Figure 1B).”
BackgroundSelf-citationEvidence for nucleosome depletion at active regulatory regions genome-wide
Lee, C.-K., Shibata, Y., Rao, B., Strahl, B. D., & Lieb, J. D. (2004) · Nature Genetics · doi:10.1038/ng1400 · Cited by 738 · cited 3×
“The objective of this study was to explore additional determinants such as the role of nucleosomal occupancy in CpG island silencing in cancer because this has been implicated in transcriptional control in yeast, flies, and humans (Bernstein et al., 2004; Heintzman et al., 2007; Lee et al., 2004; Lieb and Clarke, 2005…”
Background
Cited by
Functions of DNA methylation: islands, start sites, gene bodies and beyond
Jones, P. A. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3230 · Cited by 6,061
Self-citationA decade of exploring the cancer epigenome—biological and translational implications
Baylin, S. B., & Jones, P. A. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3130 · Cited by 2,871
“Z, that have nucleosomes positioned over the TSS and that harbour repressive histone modifications, such as H3K9me2 or H3K9me3 mark”
BackgroundSelf-citationEpigenetic modifications and human disease
Portela, A., & Esteller, M. (2010) · Nature Biotechnology · doi:10.1038/nbt.1685 · Cited by 2,836
Sharma, S., Kelly, T. K., & Jones, P. A. (2010) · Carcinogenesis · doi:10.1093/carcin/bgp220 · Cited by 2,637
Self-citationTargeting the cancer epigenome for therapy
Jones, P. A., Issa, J.-P. J., & Baylin, S. (2016) · Nature Reviews Genetics · doi:10.1038/nrg.2016.93 · Cited by 1,128
Self-citationRethinking how DNA methylation patterns are maintained
Jones, P. A., & Liang, G. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2651 · Cited by 765
Self-citationChromatin structure and the inheritance of epigenetic information
Margueron, R., & Reinberg, D. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2752 · Cited by 742
Epigenetic Antagonism between Polycomb and SWI/SNF Complexes during Oncogenic Transformation
Wilson, B. G., Wang, X., Shen, X., McKenna, E. S., Lemieux, M. E., Cho, Y.-J., Koellhoffer, E. C., Pomeroy, S. L., Orkin, S. H., & Roberts, C. W. M. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.09.006 · Cited by 654
Valouev, A., Ichikawa, J., Tonthat, T., Stuart, J., Ranade, S., Peckham, H., Zeng, K., Malek, J. A., Costa, G., McKernan, K., et al. (2008) · Genome Research · doi:10.1101/gr.076463.108 · Cited by 581
Histone modification: cause or cog?
Henikoff, S., & Shilatifard, A. (2011) · Trends in Genetics · doi:10.1016/j.tig.2011.06.006 · Cited by 482
Genome-wide mapping of nucleosome positioning and DNA methylation within individual DNA molecules
Kelly, T. K., Liu, Y., Lay, F. D., Liang, G., Berman, B. P., & Jones, P. A. (2012) · Genome Research · doi:10.1101/gr.143008.112 · Cited by 455
“Rather than using a nuclease, methyl- transferase-based footprinting, with the CpG methyltransferase M.SssI (Gal-Yam et al. 2006; Lin et al. 2007; Bouazoune et al. 2009; Kelly et al. 2010) or GpC methyltransferase M.CviPI (Kelly et al. 2010; Wolff et al. 2010; Andreu-Vieyra et al. 2011; Taberlay et…”
MethodSelf-citationCrystal Structures of Nucleosome Core Particles Containing the ‘601’ Strong Positioning Sequence
Vasudevan, D., Chua, E. Y. D., & Davey, C. A. (2010) · Journal of Molecular Biology · doi:10.1016/j.jmb.2010.08.039 · Cited by 432
Chiba, T., Marusawa, H., & Ushijima, T. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.07.009 · Cited by 381
Targeting DNA methylation for epigenetic therapy
Yang, X., Lay, F., Han, H., & Jones, P. A. (2010) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2010.08.001 · Cited by 326
Self-citationWolff, E. M., Byun, H.-M., Han, H. F., Sharma, S., Nichols, P. W., Siegmund, K. D., Yang, A. S., Jones, P. A., & Liang, G. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1000917 · Cited by 308
Self-citationAndo, T., Yoshida, T., Enomoto, S., Asada, K., Tatematsu, M., Ichinose, M., Sugiyama, T., & Ushijima, T. (2009) · International Journal of Cancer · doi:10.1002/ijc.24219 · Cited by 279
Cancer Epigenetics: Modifications, Screening, and Therapy
Einav Nili, G.-Y., Saito, Y., Egger, G., & Jones, P. A. (2008) · Annual Review of Medicine · doi:10.1146/annurev.med.59.061606.095816 · Cited by 270
Self-citationCancer DNA Methylation: Molecular Mechanisms and Clinical Implications
McCabe, M. T., Brandes, J. C., & Vertino, P. M. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2784 · Cited by 263
The Role of DNA Methylation in Cancer
Lakshminarasimhan, R., & Liang, G. (2016) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-43624-1_7 · Cited by 259
Self-citationPolycomb-Repressed Genes Have Permissive Enhancers that Initiate Reprogramming
Taberlay, P. C., Kelly, T. K., Liu, C.-C., You, J. S., De Carvalho, D. D., Miranda, T. B., Zhou, X. J., Liang, G., & Jones, P. A. (2011) · Cell · doi:10.1016/j.cell.2011.10.040 · Cited by 171
Self-citationEpigenetic regulation: A new frontier for biomedical engineers
Chen, Z., Li, S., Subramaniam, S., Shyy, J. Y.-J., & Chien, S. (2017) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071516-044720 · Cited by 163
Lau, T.-S., Chan, L. K.-Y., Wong, E. C.-H., Hui, C. W.-C., Sneddon, K., Cheung, T.-H., Yim, S.-F., Lee, J. H.-S., Yeung, C. S.-Y., Chung, T. K.-H., et al. (2017) · Oncogene · doi:10.1038/onc.2016.509 · Cited by 88
Metadata
- Authors
- Lin, J. C., Jeong, S., Liang, G., Takai, D., Fatemi, M., Tsai, Y. C., Egger, G., Gal-Yam, E. N., & Jones, P. A.
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2007-11
- Volume
- 12
- Issue
- 5
- Pages
- 432-444
- ISSN
- 1535-6108 (ISSN-L)
- OpenAlex
- W2108010006
- Cited by
- 206
- References
- 7
- FWCI
- 7.54
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.